Submission Categories
2025 Categories
3D Printing Methods
Antimicrobial Biomaterials
Bioelectronics & Wearable Sensors
BioInterfaces SIG
Biomaterial-Based Cancer Models
Biomaterial-Mediated Immune Modulation for Autoimmunity Treatment
Biomaterial-Tissue Interaction SIG
Biomaterials and Medical Products Commercialization SIG
Biomaterials Education SIG
Biomaterials for Cancer Immunotherapy
Biomaterials for functional vasculature
Biomaterials for Neural Engineering
Biomaterials for Organoids
Biomaterials for Reproductive Engineering and Women's Health
Biomaterials in the Tumor Immune Microenvironment
Biomaterials to Study Human Host-Microbiome Interactions
Biomaterials-Assisted Cell Therapy
Cardio-Pulmonary Models for Therapeutic Development and Drug Testing
Cardiovascular Biomaterials SIG
Cellular Immunotherapy
Computational and Machine Learning Approaches for Biomaterial Design & Evaluation
Dental/Craniofacial Biomaterials SIG
Drug Delivery SIG
ECM-Based Biomaterials
Engineering Cells and Their Microenvironments SIG
Engineering Solutions for Immunity in Aging Populations
Extracellular Vesicles for Biomedical Applications
Fibrous Biomaterials in Tissue Engineering
Granular & Macroporous Biomaterials for Tissue Engineering
Historically Marginalized Voices in Biomaterials Science and Engineering
Immune Biomechanics & Mechanobiology
Microfluidics and Biomaterials for Engineering 3D In Vitro Models
Nanomaterials for Immune Modulation
Nanomaterials SIG
Nanomedicine for Targeted Drug Delivery
Novel Biomaterial Developments in Non-Viral Drug Delivery Systems
Novel Materials - Biologically Inspired
Novel Materials - Design & Application
Ophthalmic Biomaterials SIG
Orthopaedic Biomaterials SIG
Pediatric Tissue Engineering
Peptide Biomaterials for Therapeutic Applications
Photonic & Metallic-Based Nanomaterials & Devices
Regenerative Biomaterials for Complex Tissue Regeneration
Regenerative Biomaterials for Traumatic Injuries
Regenerative Medicine / Tissue Engineering SIG
Sex as a Biological Variable in Biomaterials Research
Stimuli-Responsive Biomaterials
Symposium in Honor of Shelly Sakiyama-Elbert’s 50th Birthday: Celebrating 25 Years of Shaping Biomaterials in Neuroengineering
Tissue Engineering SIG
Category Descriptions
3D Printing Methods
Antimicrobial Biomaterials
Due to the threat of antibiotic resistance, biofilms, and the risk of implant-associated infections, strategies for pathogen inactivation play an increasingly important role in biomaterials development. Antimicrobial biomaterials, drug delivery systems, and surfaces that eradicate biofilms and prevent biofilm formation can prevent implant failure, improve clinical outcomes, and reduce treatment costs. This session will cover topics related to designing and characterizing biomaterials to control bacterial, viral, and/or fungal responses. Topics relating to the study of biocompatibility of pathogen-resistant surfaces; the selection and use of in vitro and preclinical models of infection; understanding the roles of biomaterials, pathogens, and hosts in biomaterial-associated infections; and the use of the One Health approach to design biomaterials to combat infections that negatively impact human, animal, and environmental health are also invited.
Bioelectronics & Wearable Sensors
Rapid advancements in soft bioelectronics and wearable sensors promise to revolutionize various fields ranging from fundamental biological research and clinical healthcare to fitness tracking and human-machine interfaces, while also enabling a shift from hospital-based to patient-centered care. This symposium will serve as a dynamic platform for academic researchers, funding agencies, and industry leaders to exchange insights on the latest advancements in soft bioelectronics and their customized applications. The scope of the symposium is broad, including but not limited to novel biomaterials and bioelectronics designs to enhance device performance, innovative manufacturing approaches, conductive scaffolds for tissue regeneration, integration of biosensors with wearable systems, machine learning and artificial intelligence for data analysis, disease diagnostics and automatic decision making, customization for specific healthcare applications, challenges and future directions of soft bioelectronics and wearable sensors, and others. This forum will foster collaboration and innovation, paving the way for next-generation, personalized healthcare technologies.
BioInterfaces SIG
The BioInterfaces Special Interest Group seeks to promote a better understanding of cell and protein interactions with biomaterial interfaces. To achieve these goals, the group organizes activities related to the evaluation of existing materials and the design of new materials to produce targeted responses by proteins and cells. Some of the topics related to proteins include: 1) relating surface chemistry to protein adsorption or specific binding and 2) studying the activation or inactivation of protein function at interfaces, including complement activation. Cell topics include: 1) the response of cells to differing chemistries and microstructures (roughness or porosity), 2) the evaluation of multiple cell and tissue response parameters (attachment, growth, migration, differentiation, inflammation, fibrosis), 3) the role of surface receptors in cell responses, and 4) all relevant cell types including bacteria. The group organizes workshops, symposia, and sessions at the annual meeting.
Biomaterial-Based Cancer Models
Biomaterial-based cancer models offer a close mimic of the complex tumor microenvironment, providing versatile platforms for screening molecular and cellular therapeutics. Such platforms enable integration of multiple cell populations and matrix compositions, treatment with patient-relevant modalities (e.g. radiation therapies), and detailed mechanistic analysis through high-resolution imaging. This symposium will highlight recent advances in leveraging biomaterial-based cancer models in vitro or in vivo, to accelerate therapeutic delivery with high efficacy and low associated toxicity.
Biomaterial-Mediated Immune Modulation for Autoimmunity Treatment
Autoimmune diseases, including multiple sclerosis and rheumatoid arthritis, affect over 24 million Americans and are among the leading causes of disability and death in the United States, disproportionately impacting women. A broad spectrum of biomaterials has been engineered to address autoimmunity by modulating immune responses via several mechanisms, such as delivering immunosuppressive drugs, inducing anti-inflammatory reactions, and enhancing regulatory immune cell functions. The proposed session aims to showcase recent studies that utilize biomaterial design to foster tolerogenic responses in the treatment of autoimmune and inflammatory conditions.
Biomaterial-Tissue Interaction SIG
Events that follow binding of the first host ion to an implant’s surface are dictated by reactions not well understood for any biomaterial or device. Understanding these events is the purpose of the Biomaterial-Tissue Interaction Special Interest Group. Only through such understanding can one definitively answer such questions as: “Why did it fail?” and “What led to its success that we can apply to future devices?” These answers will come from such fields as physiology, immunology, pathology, biomechanics and material science. They will apply to the subjects of every other SIG in the Society. All those interested in the mechanisms of host-implant interaction are welcome to join BTI's quest.
Biomaterials and Medical Products Commercialization SIG
BMPC SIG members exchange ideas and experiences about the commercialization of medical products dependent upon biomaterials for utility, efficacy, safety, and reimbursement capability. Society for Biomaterials members, ranging from students to veterans in the field, will find an open forum to explore issues facing commercial biomaterials, such as regulations, patents, litigation, reimbursement for the resultant medical device, manufacturing, and distribution with reference to hospital value analysis committees, purchasing & supply chain management system. Translation from the development to marketing of safe and innovative medical products can be improved by the proper commercial valuation of Biomaterials through current scientific inputs to assist in a better Medical Billing System. Accordingly, our mission through this SIG would be to take part in the efforts to explain the scientific, biological, and biochemical features of biomaterials to the clinical community. This process would assist any clinical value analysis team to recommend the government payers (CMS & Private Insurance) to adopt an appropriate commercial valuation for each biomaterial-based medical device in the market. Join the Biomaterials and Medical Products Commercialization SIG to enhance your knowledge and decision-making skills in the dynamic healthcare community.
Biomaterials Education SIG
The Biomaterials Education SIG members' mission is to affect quality of teaching and learning through the discussion, generation and implementation of innovative ideas. Through this, they seek to advance the interests and goals of the biomaterials community by attempting to bridge the gap between classroom theory and clinical application. As the field of biomaterials rapidly evolves, so must biomaterials education. The Biomaterials Education Special Interest Group is dedicated to the belief that all members of the biomaterials community should be provided with high quality educational opportunities in a stimulating environment.
Biomaterials for Cancer Immunotherapy
The advent of adoptive cellular immunotherapies has brought a new challenge for adequate biomanufacturing strategies to meet the demand. In this session, we will explore innovations in biomaterials and biomanufacturing related to immune cell therapies including CAR-T, CAR-M, and others.
Biomaterials for Functional Vasculature
This session will focus on the latest advancements in biomaterials designed to support the formation, maintenance, and repair of functional vasculature. Key areas of discussion will include the role of biomaterials in promoting angiogenesis and vasculogenesis, as well as biofabrication techniques such as 3D printing and bioprinting for creating complex vascular networks. Special emphasis will be placed on how biomaterial properties influence vascular cell behavior and vascular organization. Researchers will present cutting-edge ideas and advancements in translating these biomaterials and devices into clinical applications for tissue regeneration and vascular repair.
Biomaterials for Neural Engineering
Engineered biomaterials are uniquely positioned for use in creating, testing, stimulating, and regenerating neural tissue with applications like in vitro models of injury and disease, tissue engineering, therapeutic treatments, understanding neural development, and mapping or recording the brain. This session will focus on cutting edge research in neural biomaterials including fundamental material development and fabrication through pre-clinical and clinical studies spanning materials from small molecules to extracellular mimetics to neural interfaces. Such materials may be applied to big questions surrounding understanding and treating diseases and injuries of the peripheral and central nervous systems including drug, biologic, and therapeutic delivery or interventions.
Biomaterials for Organoids
Three-dimensional ex vivo organoid cultures using biomaterial-based assembly and self-assembly have been shown to resemble and recapitulate most of the functionality of diverse multicellular tissues and organs, such as the gut, brain, liver, kidney, and lung. They can be dissected and interrogated for fundamental mechanistic studies on human tissue development, regeneration and repair. They can also be used in diagnostics, disease modeling, drug discovery and personalized medicine. For example, in vitro disease models will provide cutting-edge approaches to replicate pathological conditions outside the human body. Thus, organoids bridge a gap in existing model systems by providing a more stable system that is amenable to extended cultivation and manipulation while being more representative of in vivo physiology. This session will cover the most recent advancements in biomaterials-mediated organoid and in vitro models of disease technologies in regenerative medicine, cancer therapy, drug testing, environmental control, monitoring, adaptive sensing, personalized medicine, therapeutic development and translational applications. This topic has been well-received in past SFB meetings and is an exciting emerging research area. In 2025, we will continue this session and promote translational research on the commercial viability of biomaterials-mediated organoid projects.
Biomaterials for Reproductive Engineering and Women's Health
Biomaterials in the Tumor Immune Microenvironment
Biomaterials to Study Human Host-Microbiome Interactions
Understanding the ecology as well as the mechanisms of crosstalk between the host and its microbiota will offer a more holistic view of human health that could contribute to preventing and treating a wide spectrum of human diseases. However, the field needs to ‘tool up’, as current experimental platforms cannot simultaneously support microbial communities and their native environment. This session aims to address this need, highlighting the latest approaches in modeling and decoding host-microbiome interactions in the human body. We are anticipating delving into the development, characterization of validation of biomaterial platforms able to provide native biological and metabolic conditions to sustain the long-term culture of humanized tissue systems. Innovative strategies will recreate the physical, structural and mechanical conditions of the native environment in a controlled long-term system. Bioreactors and organ-on-a-chips are emerging technologies that aim to recreate long term structural and functional features of native environments coupled with mechanical stimuli.
Biomaterials-Assisted Cell Therapy
This symposium will highlight breakthroughs in biomaterials that enhance the feasibility and translational potential of cell therapies. Biomaterials have been developed to modulate cell behavior, protect cells from immune attacks, guide patient-specific cellular activity, and stimulate endogenous cell recruitment. One key focus area will be biomaterials that augment beta cell replacement for type 1 diabetes, but the session welcomes discussions on a wide range of cell therapy applications.
Cardio-Pulmonary Models for Therapeutic Development and Drug Testing
Cardiovascular Biomaterials SIG
The Cardiovascular Biomaterials Special Interest Group has the mission to foster the professional interaction and address the common concerns of academic and industrial scientists and engineers, clinicians, and regulatory professionals concerned with the discovery, research, development, and use of biomaterials for cardiovascular devices and implants.
Cellular Immunotherapy
Computational and Machine Learning Approaches for Biomaterial Design & Evaluation
Computational modeling and machine learning can enhance our ability to design and evaluate biomaterials for a variety of applications, and have greatly improved patient care worldwide. This session will explore computational approaches and tools for designing biomaterials for tissue engineering and other applications, evaluating complex data from in vitro and in vivo studies, and predicting biomaterial performance in different microenvironments. Examples of these may include fluid mechanics and bio-transport models of drug/protein delivery, models of protein-protein and protein-material interactions, statistical modeling for biomaterial optimization, machine learning for biomaterial design and analysis, and bioinformatics-based platforms for analyzing complex data, including RNA sequencing and other -omics approaches. Progress and challenges in applying computational approaches in developing biomaterials and in patient care may be discussed.
Dental/Craniofacial Biomaterials SIG
The Dental/Craniofacial Biomaterials Special Interest Group focuses on basic, applied, and clinical biomaterials research using approaches ranging from synthetic materials to biological mechanisms of therapy, and including materials/biological constructs and tissue structure-function analyses as biomimetic/design bases. Each of these approaches converge into the larger objective of restoring oral tissue structure and function. Issues related to materials used or having potential for use intra-orally or extra-orally for the restoration, fixation, replacement, or regeneration of hard and soft tissues in and about the oral cavity and craniofacial region are included. New dental biomaterials technologies include advanced inorganic and organic materials, biomimetics, smart materials, tissue engineering, drug delivery strategies and surface modified materials.
Drug Delivery SIG
The Drug Delivery Special Interest Group will deal with the science and technology of controlled release of active agents from delivery systems. Controlled drug release is achieved by the use of diffusion, chemical reactions, dissolutions or osmosis, used either singly or in combination. While the vast majority of such delivery devices are based on polymers, controlled release can also be achieved by the use of mechanical pumps. In a broader sense, controlled release also involves control over the site of action of the active agent, using the active agent using pro-drugs, targetable water soluble polymers or various microparticulate systems. Relevant aspects of toxicology, bioavailability, pharmacokinetics, and biocompatibility are also included.
ECM-Based Biomaterials
Biomaterials derived from the extracellular matrix (ECM) have a long and rich history within both academic research and the clinical settings. Recent progress in ECM processing and bioconjugate chemistry have further aided the development of robust ECM-based materials with highly tunable physicochemical properties beyond what is achieved with traditional tissue-derived materials. From these advancements, a new utility for ECM materials has emerged ranging from components for complex 3D bioprinting to substrates for in vitro lab-on-a-chip models. This session will provide new perspectives on the emerging role of modified ECM-derived materials in various biomedical applications, including but not limited to drug delivery, stem cell bioengineering, and tissue regeneration, with a focus on commercial and clinical translational solutions.
Engineering Cells and Their Microenvironments SIG
The Engineering Cells & Their Microenvironments Special Interest Group concentrates on technologies and approaches focused at the single cell level and encompassing engineering cell microenvironments, biomaterial-induced cell signaling, stem cell manufacturing and differentiation, immunoengineering, and biomaterials for cell-based detection and diagnosis.
Engineering Solutions for Immunity in Aging Populations
Extracellular Vesicles for Biomedical Applications
Extracellular vesicles (EVs) are natural nanoparticles that carry RNA, DNA, proteins, and lipids, and have been given much attention in recent years due to the growing knowledge of their role in driving disease and maintaining health. The objective of this session is to bring together investigators focusing on the characterization and biology of EVs, engineering of EVs, and their utility as diagnostic biomarkers and therapeutics. Example topics include EV nanomaterials science, the interaction of EVs with biological systems, EV biodistribution in vivo and pharmacology, and the utility of EVs for molecular targeting, imaging, diagnostics, immunoengineering, tissue engineering, and drug delivery. EVs from different sources including both mammalian and bacteria-derived EVs will be included.
Fibrous Biomaterials in Tissue Engineering
Fibrous biomaterials represent a dynamic and rapidly evolving field at the intersection of materials science, biology, and engineering, dedicated to developing innovative solutions for complex medical challenges. From traditional bandages and gauzes to advanced vascular grafts, tendon patches, drug delivery systems, and tissue engineering scaffolds, fibrous biomaterials have revolutionized various aspects of medical treatment and procedures. This session will highlight the design, fabrication, characterization and use of fibrous biomaterials for use in tissue engineering and regenerative medicine applications.
Granular & Macroporous Biomaterials for Tissue Engineering
Historically Marginalized Voices in Biomaterials Science and Engineering
Immune Biomechanics & Mechanobiology
Evidence is emerging that the immune cells respond to the mechanical properties of their microenvironment and this can modulate their function and activation. This session will focus on immune cell interactions with biomaterials and tissues in the context of biomechanics, how this is used to modulate immune function, and how this affects immune tissue models we build.
Microfluidics and Biomaterials for Engineering 3D In Vitro Models
This session aims to explore the cutting-edge intersection of microfluidic technologies and biomaterials in the development of advanced three-dimensional (3D) in vitro models. As traditional 2D cultures fail to accurately mimic the complexity of tissues, organs, and their in vivo microenvironment, this session will explore how emerging techniques including microfluidics and organoids can be integrated with biomaterials to recreate the dynamic physiological conditions essential for accurate disease modeling, drug testing, and overall phenomena understanding. Topics will include innovations in 3D biomaterial design, the role of microfluidics in both manipulating materials for biofabrication as well as interconnecting complex on-chip cellular microenvironments, organoids, and the application of these systems in tissue engineering, cancer research, and organ-on-chip platforms. A discussion on the challenges and future directions in scaling these models for high-throughput screening and personalized medicine is to be expected.
Nanomaterials for Immune Modulation
Nanomaterials for Immune Modulation: Nanomaterials can be modified to target specialized biomolecules, cells and tissues of the immune system. These nanomaterials range from chemically modified macromolecules, peptides, proteins, or other similar materials. This session will focus on developing nanomaterials that modulate immune responses for a range of diseases.
Nanomaterials SIG
The mission of the Nanomaterials SIG is to advocate for and organize the exchange of ideas involving the unique science and technology present in biomaterials at the nanoscale. By focusing on science, the SIG will champion the continual push to uncover new knowledge at the nanoscale and connect this to macroscale properties and behaviors of biomaterials. Through its focus on technology, the SIG will foster innovative design and synthesis of nanobiomaterials useful in the creation of new and better devices, diagnostics and therapeutics for biomedical applications. The SIG emphasizes an interdisciplinary vision to facilitate the translation of nanomaterials to achieve intended biological significance and medical impact. The vision is to establish the NanoSIG to become a thought leader in the nanobiomaterials research community by emphasizing nanoscience discovery, nanotechnology application, and clinical translation innovation.
Nanomedicine for Targeted Drug Delivery
This session will emphasize product development and translational nanomedicine, including but not limited to evaluation of product effectiveness in vivo in disease models, nanomedicine manufacturing, and nanomedicine quality control for specific applications. Nanomedicines include colloids and other nanomaterials that have been engineered to target delivery of diverse payloads (such as small molecules, nucleic acids, or biologics) to specific cells or tissues. Targeting approaches may include but are not restricted to cell membrane coating, surface modification, engineering of particle geometry, or engineering other biophysical parameters. Abstracts from academic researchers with translational products or devices are welcomed and abstracts from industry members are especially encouraged.
Novel Biomaterial Developments in Non-Viral Drug Delivery Systems
Nucleic acid-based therapies or genetic medicines have the potential to treat a wide variety of conditions. Heavy reliance on viral methods, however, can hamper clinical translation and widespread use of such therapies. Non-viral approaches are required to avoid the risk of adverse immune reactions, enable redosing, and make nucleic acid-based therapies more affordable. This session will focus on showcasing biomaterials-based approaches to non-viral nucleic acid-based therapies. We encourage contributions spanning a wide range of biomaterials research applications, including the development of novel carrier systems (e.g., polymer- and lipid-based nanocarriers, engineered extracellular vesicles, physical methods, etc.), methods of deployment (e.g., controlled release, novel routes of administration, etc.), and therapeutic cargo (e.g., novel nucleic acid designs, aptamers, etc.), among others.
Novel Materials - Biologically Inspired
Bioinspiration from nature can be drawn through structural, functional, or organizational properties. With their tunable properties, bioinspired materials can mimic different aspects of natural structures and have shown promise in various clinical applications. For example, they have been used as biomimetic scaffolds in tissue engineering and regenerative medicine to promote tissue healing and integration. In drug delivery, bioinspired materials can be designed for targeted and controlled release, improving efficacy, reducing side effects, and ensuring a consistent therapeutic effect. Additionally, bioinspired materials are utilized in implants and medical devices due to their integration with the body, which reduces the risk of rejection and improves longevity.
While bioinspired materials are cytocompatible, effective, and sustainable compared to traditional materials for clinical applications, there are challenges in clinical translation including regulatory aspects.
Our symposium will focus on exploring innovative bioinspired biomaterials and technologies aimed at overcoming these key challenges and advancing their clinical translation. We will feature perspectives from academic research, industry collaborations, and the commercialization of cutting-edge biomaterials and technologies inspired by biological systems. Additionally, we will address emerging challenges and explore ways to foster new collaborations. Our symposium will be of interest to medical researchers, academic professionals, and industry participants.
Novel Materials - Design & Application
Ophthalmic Biomaterials SIG
The Ophthalmic Biomaterials Special Interest Group focuses on both the development and biocompatibility testing of materials for the augmentation and replacement of diseased ocular tissues and the development and testing of drug delivery systems to the anterior and posterior segments of the eye. Some specific areas of interest include but are not limited to: wetting of surfaces; surface modification and protein adsorption of polymers used for refractive devices; transport through polymers, drug delivery systems, and technologies; vitreous replacement fluids; retinal tamponades, and glaucoma drainage devices for the regulation of intraocular pressure.
Orthopaedic Biomaterials SIG
The Orthopaedic Biomaterials Special Interest Group is focusing on new technologies and materials advances in orthopaedic surgery. The three immediate goals of this emerging Special Interest Group are: 1) solicitation of new members for the Special Interest Group from current Society membership and from non-members actively engaged in research and development of improved materials for orthopaedics, 2) identification of key issues in orthopaedic materials that should be addressed within the Society, and 3) cooperation between Special Interest Group membership and the chairman of the Program Committee for the Annual Meeting to assist in the coordination of the scientific program.
Pediatric Tissue Engineering
Peptide Biomaterials for Therapeutic Applications
Peptides are chemically defined and possess a wide range of biofunctions including ligand binding, proteolytic susceptibility, and self-assembly. Owing to these features, peptide-based biomaterials show wide range of capacities to encapsulate payload, to engage cellular receptors, to respond to stimuli and surrounding environments, and to modulate cell functions as drug or immune antigens. We will feature recent advances in the development of biomaterials including, but not limited to, peptides acting as bioactive components, peptides functioning as targeting ligands, and peptides serving as scaffold building blocks, for therapeutic applications.
Photonic & Metallic-Based Nanomaterials & Devices
This workshop will explore the latest advancements in emerging photonic nanomaterials and devices, bioabsorbable metallic alloys and composites. The focus will be on advanced photonic and metallic nanomaterials, their synthesis and characterization methods, understanding material structure-property relationships, material-tissue interactions, in vivo studies, and their potential biomedical applications. The topics to be covered will include (1) photonic nanomaterials and devices for healthcare applications, and (2) metallic biomaterials on patient care and medical implants.
Regenerative Biomaterials for Complex Tissue Regeneration
Regenerative Biomaterials for Traumatic Injuries
Regenerative Medicine / Tissue Engineering SIG
Sex as a Biological Variable in Biomaterials Research
Stimuli-Responsive Biomaterials
Materials that respond to environmental stimuli, such as heat, light, pH, or biological signals, provide unique tools for environmentally-responsive and/or temporal changes in biomaterial properties over time. This session will focus on materials, including hybrid materials, that can be stimulated with a variety of physiological and external stimuli to achieve desired outcomes. Research related to the use of stimuli-responsive materials that respond to endogenous or exogenous signals to (1) trigger drug delivery, (2) study and control the cellular response to microenvironmental changes, and/or (3) drive tissue regeneration and disease treatment is of particular interest.
Symposium in Honor of Shelly Sakiyama-Elbert’s 50th Birthday: Celebrating 25 Years of Shaping Biomaterials in Neuroengineering
Tissue Engineering SIG
Tissue Engineering SIG is a forum to exchange information, further knowledge, and promote greater awareness regarding all aspects of the use of biomaterials to engineering tissue substitutes or to promote tissue regeneration. Of primary interest and relevance to TE SIG is the use of appropriate materials (synthetic and natural) with cells (either native or from a donor source) and/or biological response modifiers (e.g., growth factors, cytokines and other recombinant products) to replace tissue and organ functions. Particular emphasis is placed on the development of materials to better incorporate, protect, and deliver both the cells and biological response modifiers to help promote the healing and regenerative processes. The group is committed to forging interactions among basic scientists, applied scientists, engineers, clinicians, industrial members, professional societies in related fields, and regulatory groups in its efforts to expand and effectively utilize the shared knowledge base in this multidisciplinary field.
HOW DOES AN IDEA BECOME A SESSION?